IDEAS home Printed from https://ideas.repec.org/a/adp/jctbeb/v1y2016i2p32-40.html
   My bibliography  Save this article

Advances in the Therapy of Advanced Ovarian Cancer-Special Emphasis on the PD1/PDL1 Pathway

Author

Listed:
  • Kulvinder Kochar Kaur
  • Gautam Allahbadia

    (Department of Human Physiology, Gregory University, Nigeria)

  • Mandeep Singh

    (Consultant Neurologist, Centre for Human Reproduction, India)

Abstract

Ovarian Cancer gets diagnosed in advanced stage in 75% of patient and thus remains one of the most lethal gynecological malignancies. Despite 80% patients being responsive to platinum based chemotherapies to start with most relapse finally. Hence need of the hour is to find more effective immunotherapy’s to be added to these CRT. Programmed cell death1 (PD1) -PDL1 is an important immune pathway which is discussed in detail along with role of nivelumab (a monoclonal antibody against PD1) and addition of other immunotherapy’s like bevacizumab, Olafarib (A PARP (polyadenosine diphosphate (ADP)-ribose- inhibitor), C edinarib (a VEGF123 inhibitor) etc to increase five year survival. Reasons of why success not obtained as expected is further sought through Effect of IFNγ on PDL1 pathway and different NK cellular phenotypes is further analyzed besides role of NACT (neoadjunctive chemotherapy) on induction of immune response.

Suggested Citation

  • Kulvinder Kochar Kaur & Gautam Allahbadia & Mandeep Singh, 2016. "Advances in the Therapy of Advanced Ovarian Cancer-Special Emphasis on the PD1/PDL1 Pathway," Current Trends in Biomedical Engineering & Biosciences, Juniper Publishers Inc., vol. 1(2), pages 32-40, December.
    • Handle: RePEc:adp:jctbeb:v:1:y:2016:i:2:p:32-40
    DOI: 10.19080/CTBEB.2016.01.555557
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/ctbeb/pdf/CTBEB.MS.ID.555557.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/ctbeb/CTBEB.MS.ID.555557.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/CTBEB.2016.01.555557?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Jacques Banchereau & Ralph M. Steinman, 1998. "Dendritic cells and the control of immunity," Nature, Nature, vol. 392(6673), pages 245-252, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Thanh Loc Nguyen & Youngjin Choi & Jihye Im & Hyunsu Shin & Ngoc Man Phan & Min Kyung Kim & Seung Woo Choi & Jaeyun Kim, 2022. "Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    2. Bangyuan Wu & Hengmin Cui & Xi Peng & Jing Fang & Zhicai Zuo & Junliang Deng & Jianying Huang, 2014. "Analysis of the Toll-Like Receptor 2-2 (TLR2-2) and TLR4 mRNA Expression in the Intestinal Mucosal Immunity of Broilers Fed on Diets Supplemented with Nickel Chloride," IJERPH, MDPI, vol. 11(1), pages 1-14, January.
    3. Iraj Hosseini & Lucio Gama & Feilim Mac Gabhann, 2015. "Multiplexed Component Analysis to Identify Genes Contributing to the Immune Response during Acute SIV Infection," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-28, May.
    4. Kalijn F. Bol & Gerty Schreibelt & Martine Bloemendal & Wouter W. Willigen & Simone Hins-de Bree & Anna L. Goede & Annemiek J. Boer & Kevin J. H. Bos & Tjitske Duiveman-de Boer & Michel A. M. Olde Nor, 2024. "Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    5. Caroline Hoffmann & Floriane Noel & Maximilien Grandclaudon & Lucile Massenet-Regad & Paula Michea & Philemon Sirven & Lilith Faucheux & Aurore Surun & Olivier Lantz & Mylene Bohec & Jian Ye & Weihua , 2022. "PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    6. Dominic Henn & Dehua Zhao & Dharshan Sivaraj & Artem Trotsyuk & Clark Andrew Bonham & Katharina S. Fischer & Tim Kehl & Tobias Fehlmann & Autumn H. Greco & Hudson C. Kussie & Sylvia E. Moortgat Illouz, 2023. "Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healing," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    7. Yael Korem & Pablo Szekely & Yuval Hart & Hila Sheftel & Jean Hausser & Avi Mayo & Michael E Rothenberg & Tomer Kalisky & Uri Alon, 2015. "Geometry of the Gene Expression Space of Individual Cells," PLOS Computational Biology, Public Library of Science, vol. 11(7), pages 1-27, July.
    8. Sahil Inamdar & Abhirami P. Suresh & Joslyn L. Mangal & Nathan D. Ng & Alison Sundem & Christopher Wu & Kelly Lintecum & Abhirami Thumsi & Taravat Khodaei & Michelle Halim & Nicole Appel & Madhan Moha, 2023. "Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jctbeb:v:1:y:2016:i:2:p:32-40. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.